228 related articles for article (PubMed ID: 9794400)
1. Ligation of cell surface CD38 protein with agonistic monoclonal antibody induces a cell growth signal in myeloid leukemia cells.
Konopleva M; Estrov Z; Zhao S; Andreeff M; Mehta K
J Immunol; 1998 Nov; 161(9):4702-8. PubMed ID: 9794400
[TBL] [Abstract][Full Text] [Related]
2. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
3. Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines.
Inoue S; Kontani K; Tsujimoto N; Kanda Y; Hosoda N; Hoshino S; Hazeki O; Katada T
J Immunol; 1997 Dec; 159(11):5226-32. PubMed ID: 9548461
[TBL] [Abstract][Full Text] [Related]
4. CD38-mediated signaling events in murine pro-B cells expressing human CD38 with or without its cytoplasmic domain.
Kitanaka A; Suzuki T; Ito C; Nishigaki H; Coustan-Smith E; Tanaka T; Kubota Y; Campana D
J Immunol; 1999 Feb; 162(4):1952-8. PubMed ID: 9973464
[TBL] [Abstract][Full Text] [Related]
5. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.
Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS
J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576
[TBL] [Abstract][Full Text] [Related]
7. IL-5 induces IgG1 isotype switch recombination in mouse CD38-activated sIgD-positive B lymphocytes.
Mizoguchi C; Uehara S; Akira S; Takatsu K
J Immunol; 1999 Mar; 162(5):2812-9. PubMed ID: 10072528
[TBL] [Abstract][Full Text] [Related]
8. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
[TBL] [Abstract][Full Text] [Related]
9. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
[TBL] [Abstract][Full Text] [Related]
10. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells.
Zupo S; Rugari E; Dono M; Taborelli G; Malavasi F; Ferrarini M
Eur J Immunol; 1994 May; 24(5):1218-22. PubMed ID: 8181532
[TBL] [Abstract][Full Text] [Related]
11. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
Ferrero D; Cherasco C; Ortolano B; Giaretta F; Bruno B
Haematologica; 1999 May; 84(5):390-6. PubMed ID: 10329916
[TBL] [Abstract][Full Text] [Related]
12. Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
Lund FE; Yu N; Kim KM; Reth M; Howard MC
J Immunol; 1996 Aug; 157(4):1455-67. PubMed ID: 8759726
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.
Funaro A; Spagnoli GC; Ausiello CM; Alessio M; Roggero S; Delia D; Zaccolo M; Malavasi F
J Immunol; 1990 Oct; 145(8):2390-6. PubMed ID: 1976692
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
Balaian L; Ball ED
Exp Hematol; 2005 Feb; 33(2):199-211. PubMed ID: 15676214
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells.
Yamashita Y; Miyake K; Kikuchi Y; Takatsu K; Noda S; Kosugi A; Kimoto M
Immunology; 1995 Jun; 85(2):248-55. PubMed ID: 7642213
[TBL] [Abstract][Full Text] [Related]
16. Nuclear CD38 in retinoic acid-induced HL-60 cells.
Yalcintepe L; Albeniz I; Adin-Cinar S; Tiryaki D; Bermek E; Graeff RM; Lee HC
Exp Cell Res; 2005 Feb; 303(1):14-21. PubMed ID: 15572023
[TBL] [Abstract][Full Text] [Related]
17. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
18. Surface antigen detection with non-fluorescent, antibody-coated microbeads: an alternative method compatible with conventional fluorochrome-based labeling.
Fortin M; Hugo P
Cytometry; 1999 May; 36(1):27-35. PubMed ID: 10331624
[TBL] [Abstract][Full Text] [Related]
19. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
van Rhenen A; Feller N; Kelder A; Westra AH; Rombouts E; Zweegman S; van der Pol MA; Waisfisz Q; Ossenkoppele GJ; Schuurhuis GJ
Clin Cancer Res; 2005 Sep; 11(18):6520-7. PubMed ID: 16166428
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric characterization of acute myeloid leukemia: IV. Comparison to the differentiation pathway of normal hematopoietic progenitor cells.
Terstappen LW; Safford M; Unterhalt M; Könemann S; Zurlutter K; Piechotka K; Drescher M; Aul C; Büchner T; Hiddemann W
Leukemia; 1992 Oct; 6(10):993-1000. PubMed ID: 1383649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
